6.6-cm Haemorrhagic Ovarian Cyst: Non-Visualization at 98-Day Follow-Up Following the Dr. S. M. Raju-Defined Neo Ayurveda Treatment Protocol

Background: Haemorrhagic ovarian cysts may present with abnormal uterine bleeding, pelvic or abdominal pain, weakness, and other associated symptoms. Management depends on cyst characteristics, persistence, symptom severity, and clinical assessment, with surgical intervention considered in selected cases. Neo Ayurveda is an integrative treatment approach developed by Dr. S. M. Raju based on approximately four decades of observational work and incorporates proprietary herbal formulations, dietary modification, prebiotic and probiotic principles, and nutritional strategies intended to support cellular metabolism, mitochondrial function, gut health, and the body's intrinsic reparative processes. Case Presentation: A 23-year-old woman presented with polymenorrhoea, irregular bleeding, abdominal pain, weakness, gastritis, and a sensation of heaviness in the chest. Ultrasonography of the abdomen dated 10 April 2026 demonstrated a left ovarian cyst measuring 6.6 × 5.8 × 6.0 cm, showing a thin reticular pattern and internal echoes, reported as being suggestive of a haemorrhagic ovarian cyst. According to the patient's subsequent oral testimony, surgical removal had been advised; however, the patient and her family elected to pursue a non-surgical approach. Intervention: A structured Neo Ayurveda protocol was initiated on 10 June 2026 under clinical supervision. The protocol included proprietary herbal formulations directed toward systemic, cardiovascular, gastrointestinal, immune, and metabolic support, together with Graviola 500 mg and a defined dietary program. The nutritional regimen incorporated garlic, ginger, soaked fenugreek seeds, a flaxseed–flax oil–yogurt preparation, leached raw vegetable juice, increased intake of vegetables, leafy vegetables, fruits and dry fruits, restricted fried and processed foods, and a predominantly plantbased dietary pattern. The intervention was designed according to the Dr. Raju Cell Regeneration Principle, which proposes that nutritional support, detoxification, gut microbial support, improved microcirculation, mitochondrial activation, and cellular protein-homeostasis mechanisms may contribute to functional recovery in stressed or degenerative tissues. These proposed mechanisms remain hypotheses requiring independent experimental and clinical validation. Outcome: During the treatment period, the patient reported progressive resolution of abnormal bleeding, abdominal discomfort, weakness, gastritis, and associated physical symptoms. Follow-up ultrasonography performed on 16 September 2026, approximately 98 days after initiation of the protocol, did not demonstrate the previously documented ovarian cyst, and the study was reported as showing no significant abnormality. A video-recorded patient statement obtained on 19 September 2026 described substantial symptomatic recovery without surgical intervention.

Authors

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-14
DOI
https://doi.org/10.25258/ijddt.16.90s.137
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

6.6-cm Haemorrhagic Ovarian Cyst: Non-Visualization at 98-Day Follow-Up Following the Dr. S. M. Raju-Defined Neo Ayurveda Treatment Protocol

S. M. Raju, Ms. Jasmine, Vallari Poojari
International Journal of Drug Delivery Technology
Ovarian function and disorders
article

6.6-cm Haemorrhagic Ovarian Cyst: Non-Visualization at 98-Day Follow-Up Following the Dr. S. M. Raju-Defined Neo Ayurveda Treatment Protocol

S. M. Raju, Ms. Jasmine, Vallari Poojari
article en

Abstract

Background: Haemorrhagic ovarian cysts may present with abnormal uterine bleeding, pelvic or abdominal pain, weakness, and other associated symptoms. Management depends on cyst characteristics, persistence, symptom severity, and clinical assessment, with surgical intervention considered in selected cases. Neo Ayurveda is an integrative treatment approach developed by Dr. S. M. Raju based on approximately four decades of observational work and incorporates proprietary herbal formulations, dietary modification, prebiotic and probiotic principles, and nutritional strategies intended to support cellular metabolism, mitochondrial function, gut health, and the body's intrinsic reparative processes. Case Presentation: A 23-year-old woman presented with polymenorrhoea, irregular bleeding, abdominal pain, weakness, gastritis, and a sensation of heaviness in the chest. Ultrasonography of the abdomen dated 10 April 2026 demonstrated a left ovarian cyst measuring 6.6 × 5.8 × 6.0 cm, showing a thin reticular pattern and internal echoes, reported as being suggestive of a haemorrhagic ovarian cyst. According to the patient's subsequent oral testimony, surgical removal had been advised; however, the patient and her family elected to pursue a non-surgical approach. Intervention: A structured Neo Ayurveda protocol was initiated on 10 June 2026 under clinical supervision. The protocol included proprietary herbal formulations directed toward systemic, cardiovascular, gastrointestinal, immune, and metabolic support, together with Graviola 500 mg and a defined dietary program. The nutritional regimen incorporated garlic, ginger, soaked fenugreek seeds, a flaxseed–flax oil–yogurt preparation, leached raw vegetable juice, increased intake of vegetables, leafy vegetables, fruits and dry fruits, restricted fried and processed foods, and a predominantly plantbased dietary pattern. The intervention was designed according to the Dr. Raju Cell Regeneration Principle, which proposes that nutritional support, detoxification, gut microbial support, improved microcirculation, mitochondrial activation, and cellular protein-homeostasis mechanisms may contribute to functional recovery in stressed or degenerative tissues. These proposed mechanisms remain hypotheses requiring independent experimental and clinical validation. Outcome: During the treatment period, the patient reported progressive resolution of abnormal bleeding, abdominal discomfort, weakness, gastritis, and associated physical symptoms. Follow-up ultrasonography performed on 16 September 2026, approximately 98 days after initiation of the protocol, did not demonstrate the previously documented ovarian cyst, and the study was reported as showing no significant abnormality. A video-recorded patient statement obtained on 19 September 2026 described substantial symptomatic recovery without surgical intervention.

International Journal of Drug Delivery TechnologyVol. 16(90s)
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon